SIMILASAN Rhume liquide glob 15 g

7680506720430 CH-50672 20.01.1.
SIMILASAN Rhume liquide glob 15 g
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5067201
CPT
-
Packaging group
15
Unit
g
Composition
allium cepa (HAB) D4 8.500 mg, allium cepa (HAB) D10 1.000 mg, allium cepa (HAB) D15 0.500 mg, calcii carbonas, xylitolum, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Fliess-Schnupfen, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/06/2022
Patient information leaflet
Français
24/06/2022
Patient information leaflet
Italien
24/06/2022

Detailed composition

Substance Quantity Type Category
allium cepa (HAB)
8.5 MG Substance Wirkstoff (Principe actif)
allium cepa (HAB)
1.0 MG Substance Wirkstoff (Principe actif)
allium cepa (HAB)
0.5 MG Substance Wirkstoff (Principe actif)
calcii carbonas
- Substance HNIDK
xylitolum
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50672
Drug name
Similasan Fliess-Schnupfen, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
17/10/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Erkältungsschnupfen, allergischem Schnupfen, Heuschnupfen und nervösem Schnupfen mit reichlicher, wundmachender, wässriger Absonderung; Triefendem Schnupfen mit Tränenfluss, wunden Nasenlöchern

Packaging details

Description (FR)
SIMILASAN Rhume liquide glob 15 g
Description (DE)
SIMILASAN Fliess-Schnupfen Glob 15 g
Market launch
17/10/1991
Narcotic (BTM)
No

Other packaging sizes

Buy us a coffee Explore the data